Cleveland Clinic opens new cancer center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The new Cleveland Clinic Taussig Cancer Center will begin welcoming patients March 6.

The 377,000-square-foot facility, estimated at $276 million, will house all outpatient cancer treatment services in one location. The seven-story cancer building is located on the north side of Carnegie Avenue between East 102nd and 105th Streets.

The building, designed by William Rawn Associates, Architects, Inc. and Stantec Architecture, is organized by cancer type, allowing patients to now have all of their appointments in one area where clinical caregivers come to the patient.

“As one of the nation’s most progressive cancer centers, the new Taussig Cancer Center will provide a seamless, personalized experience,” said Brian Bolwell, chairman of the Cleveland Clinic Taussig Cancer Institute. “Our design priorities of reduced wait times, improved patient flow, multidisciplinary clinics and a healing environment, combined with a commitment to cancer research, will deliver the best possible care and support for our patients.”

The new building includes an open first level featuring a large laboratory to help avoid long waits for blood testing; an outpatient pharmacy; a retail store stocked with items to meet cancer patients’ needs; and a café that accommodates special diets. Clinical features of the Cleveland Clinic Taussig Cancer Center include:

  • 126 exams rooms and 98 treatment rooms in close proximity

  • Private chemotherapy infusion suites along the north side of the building with floor-to-ceiling windows that overlook the tree-lined lawn

  • Genetics and genomics testing

  • A centralized home for existing high-level treatment technology, including six linear accelerators and a Gamma Knife suite

  • On-site diagnostic imaging

  • Dedicated area for phase I, II and III clinical trials, with a special emphasis on supporting phase I trials

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login